Publications by authors named "Daniel Cordonnier"

Claim this Profile
[
[Microalbuminuria and urinary albumin excretion: clinical practice guidelines].
Jean-Michel Halimi, Samy Hadjadj, Victor Aboyans, François-André Allaert, Jean-Yves Artigou, Daniel Cordonnier

Nephrol Ther· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transforming growth factor-beta in human diabetic nephropathy: effects of ACE inhibition.
Robyn G Langham, Darren J Kelly, Renae M Gow, Yuan Zhang, Daniel J Cordonnier

Diabetes Care· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations.
Marc A Pohl, Samuel Blumenthal, Daniel J Cordonnier, Fernando De Alvaro, Giacomo Deferrari

J Am Soc Nephrol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of irbesartan in diabetic nephropathy: a systematic review of published studies.
Andrew J Palmer, Daniel M D Tucker, William J Valentine, Stéphane Roze, Sylvie Gabriel, Daniel J Cordonnier

Nephrol Dial Transplant· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient referral is influenced by dialysis centre structure in the Diamant Alpin Dialysis cohort study.
Jean-Pierre Wauters, Jean-Luc Bosson, Giacomo Forneris, Cécile Turc-Baron, Dela Golshayan, Daniel Cordonnier

Nephrol Dial Transplant· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients.
Gilles Pernod, Jean-Luc Bosson, Dela Golshayan, Claire Barro, Sandro Alloatti, Daniel Cordonnier

J Nephrol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An economic evaluation of irbesartan in the treatment of patients with type 2 diabetes, hypertension and nephropathy: cost-effectiveness of Irbesartan in Diabetic Nephropathy Trial (IDNT) in the Belgian and French settings.
Andrew J Palmer, Lieven Annemans, Stephane Roze, Mark Lamotte, Roger A Rodby, Daniel J Cordonnier

Nephrol Dial Transplant· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis